Treace Medical Concepts Faces Stock Drop After Q1 Financial Results

The Law Offices of Frank R. Cruz is investigating Treace Medical Concepts, Inc. (“Treace” or the “Company”) TMCI for potential violations of federal securities laws. This investigation is in response to concerns raised by investors and the actions of the Company’s officers.

Shareholders who have experienced financial losses are encouraged to participate in this investigation.

Treace’s financial challenges became evident on May 7, 2024, when it announced its first quarter financial results. The Company revised its full year guidance downward by approximately $20 million. The adjustment was attributed to increased competition from similar products and a higher adoption rate of Minimally Invasive Surgery (MIS) Osteotomy solutions, impacting sales of its Lapiplasty products.

Following this announcement, Treace’s stock price plummeted by $6.95, marking a significant 62.5% decline to close at $4.17 per share on May 8, 2024. This drastic drop has affected numerous investors adversely.

Stay informed with updates on our Twitter page: twitter.com/FRC_LAW.

If you purchased Treace securities or have information related to these claims, or if you have questions regarding this announcement, please reach out to Frank R. Cruz at The Law Offices of Frank R. Cruz. The office is located at 2121 Avenue of the Stars, Suite 800, Los Angeles, California 90067. You can call at 310-914-5007 or email at info@frankcruzlaw.com. When contacting by email, please include your mailing address, phone number, and number of shares purchased.

This press release may qualify as Attorney Advertising under certain jurisdictions and ethical guidelines.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250109575722/en/

The Law Offices of Frank R. Cruz, Los Angeles

Frank R. Cruz, 310-914-5007

fcruz@frankcruzlaw.com

www.frankcruzlaw.com